ROYAL BANK OF CANADA - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 27 filers reported holding ACASTI PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q2 2021$1,0000.0%2,213
+5.4%
0.00%
Q1 2021$1,0000.0%2,1000.0%0.00%
Q4 2020$1,0002,1000.0%0.00%
Q3 2020$0
-100.0%
2,100
-67.5%
0.00%
Q2 2020$3,000
+200.0%
6,461
+77.8%
0.00%
Q1 2020$1,000
-85.7%
3,633
+26.1%
0.00%
Q4 2019$7,000
+75.0%
2,880
+38.8%
0.00%
Q3 2019$4,000
-20.0%
2,075
-49.5%
0.00%
Q2 2019$5,000
-44.4%
4,109
-51.7%
0.00%
Q1 2019$9,000
+200.0%
8,502
+108.6%
0.00%
Q4 2018$3,000
-40.0%
4,0750.0%0.00%
Q3 2018$5,000
+66.7%
4,075
-25.8%
0.00%
Q2 2018$3,000
-25.0%
5,493
+34.8%
0.00%
Q1 2018$4,0004,075
+5333.3%
0.00%
Q4 2017$0750.0%0.00%
Q3 2017$0750.0%0.00%
Q2 2017$0750.0%0.00%
Q1 2017$075
-6.2%
0.00%
Q4 2016$080
+6.7%
0.00%
Q3 2016$0
-100.0%
75
-87.0%
0.00%
Q2 2016$1,0000.0%5750.0%0.00%
Q1 2016$1,0000.0%575
-2.2%
0.00%
Q4 2015$1,0005880.00%
Other shareholders
ACASTI PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Perceptive Advisors 236,559$594,0000.04%
INTACT INVESTMENT MANAGEMENT INC. 89,490$287,0000.01%
BANK OF MONTREAL /CAN/ 210,484$537,0000.00%
DEUTSCHE BANK AG\ 215$00.00%
Tower Research Capital LLC (TRC) 200$1,0000.00%
CITIGROUP INC 30$00.00%
MORGAN STANLEY 18$00.00%
Renaissance Technologies 20,900$53,0000.00%
ROYAL BANK OF CANADA 588$1,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 400$1,0000.00%
View complete list of ACASTI PHARMA INC shareholders